SARS-CoV-2 Variants - Coronavirus COVID-19 **NO DISCUSSION**

  • #221
  • #222
  • #223

Statement on the antigen composition of COVID-19 vaccines​

26 April 2024

  • “SARS-CoV-2 continues to circulate and evolve with important genetic and antigenic evolution of the spike protein.

  • The objective of an update to COVID-19 vaccine antigen composition is to enhance vaccine-induced immune responses to circulating SARS-CoV-2 variants.

  • As the virus is expected to continue to evolve from JN.1, the TAG-CO-VAC advises the use of a monovalent JN.1 lineage as the antigen in future formulations of COVID-19 vaccines.

  • In accordance with WHO SAGE policy, vaccination programmes should continue to use any of the WHO emergency-use listed or prequalified COVID-19 vaccines and vaccination should not be delayed in anticipation of access to vaccines with an updated composition.”


* more at link
 
  • #224

Members online

Online statistics

Members online
125
Guests online
2,552
Total visitors
2,677

Forum statistics

Threads
632,675
Messages
18,630,297
Members
243,245
Latest member
St33l
Back
Top